Effects of eicosapentaenoic acid on biochemical failure after radical prostatectomy for prostate cancer

In Vivo

Volumn 24, Issue 4, 2010, Pages 561-565

  Higashihara, Eiji ^a   Itomura, Miho ^b   Terachi, Toshiro ^c   Matsuda, Tadashi ^d   Kawakita, Mutushi ^e   Kameyama, Shuji ^f   Fuse, Hideki ^b   Chiba, Yutaka ^g   Hamazaki, Tomohito ^b   Okegawa, Takatsugu ^a   Tokunaga, Masatoshi ^c   Murota, Takashi ^d   Kawa, Gen ^d   Furuya, Yuzo ^b   Akashi, Takuya ^b   Hamazaki, Kei ^b   Takada, Hideho ^d  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

^c TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KANSAI MEDICAL UNIVERSITY   (Japan)

^e KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^f NTT CORPORATION   (Japan)

^g TOHOKU ROSAI HOSPITAL   (Japan)

Author keywords

Eicosapentaenoic acid; Omega 3 polyunsaturated fatty acids; Prostate cancer; Prostate specific antigen

Indexed keywords

DOCOSAHEXAENOIC ACID; EPADEL S; ICOSAPENTAENOIC ACID; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

AGED; APOPTOSIS; ARTICLE; CANCER RECURRENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; DRUG EFFICACY; ERYTHROCYTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE;

EID: 77955888019     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE and Mack TM: Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 63: 963-966, 1991.
2. Terry P, Lichtenstein P, Feychting M, Ahlbom A and Wolk A: Fatty fish consumption and risk of prostate cancer. Lancet 357: 1764-1766, 2001. (Pubitemid 32524210)
3. Augustsson K, Michaud DS, Rimm EB Leitzmann MF, Stampfer MJ, Willett WC and Giovannucci E: A prospective study of intake of fish and marine fatty acids and prostate cancer. Cancer Epidemiol Biomakers prev 12: 64-67, 2003. (Pubitemid 36110160)
4. Sonoda T, Nagata Y, Mori M, Miyanaga N, Takashima N, Okumura K, Goto K, Naito S, Fujimoto K, Hirao Y, Takahashi A, Tsukamoto T, Fujioka T and Akaza H: A case-control study of diet and prostate cancer in Japan: Possible protective effect of traditional Japanese diet. Cancer Sci 95: 238-242, 2004.
5. Astorg P: Dietary n-6 and n-3 polyunsaturated fatty acids and prostate cancer risk: a review of epidemiological and experimental evidence. Cancer Causes Control 15: 367-386, 2004.
6. Wallstrom P, Bjartell A, Gullberg B, Olsson H and Wirfalt E: A prospective study on dietary fat and incidence of prostate cancer (Malmo, Sweden). Cancer Causes Control 18: 1107-1121, 2007.
7. Kobayashi N, Barnard RJ, Henning SM, Elashoff D, Reddy ST, Cohen P, Leung P, Hong-Gonzalez J, Freedland SJ, Said J, Gui D, Seeram NP, Popoviciu LM, Bagga D, Heber D, Glaspy JA and Aronson WJ: Effect of altering dietary ω-6/ω-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2. Clin Cancer Res 12: 4662-4670, 2006.
8. Kelavkar U, Hutzley J, Dhir R, Kim P, Allen KGD and Mchugh K: Prostate tumor growth and recurrence can be modulated by the ω-6: ω-3 ratio in diet: Athymic mouse xenograft model simulating radical prostatectomy. Neoplasia 8: 112-124, 2006.
9. Berquin IM, Min Y, Wu R, Wu J, Perry D, Cline JM Thomas MJ, Thornburg T, Kulik G, Smith A, Edwards IJ, D'Agostino R Jr, Zhang H, Wu H, Kang JX and Chen YQ: Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids. J Clin Invest 117: 1866-1875, 2007.
10. Harvei S, Bjerve KS, Tretli S, Jellum E, Robsahm TE and Vatten L: Prediagnostic level of fatty acids in serum phospholipids: Omega-3 and omega-6 fatty acids and the risk of prostate cancer. Int J Cancer 71: 545-551, 1997. (Pubitemid 27239362)
11. Leitzmann MF, Stampfer MJ, Michaud DS, Augustsson K, Colditz GC, Willett WC and Giovannucci EL: Dietary intake of n-3 and n-6 fatty acids and the risk of prostate cancer. Am J Clin Nutr 80: 204-216, 2004.
12. Chavarro JE, Stampfer MJ, Li H, Campos H, Kurth T and Ma J: A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk. Cancer Epidemiol Biomakers prev 16: 1364-1370, 2007. (Pubitemid 47076865)
13. Norrish AE, Skeaff CM, Arribas GLB, Sharpe SJ and Jackson RT: Prostate cancer risk and consumption of fish oils: A dietary biomarker-based case-control study. Br J Cancer 81: 1238-1242, 1999.
14. Yang YJ, Lee SH, Hong SJ and Chung BC: Comparison of fatty acid profiles in the serum of patients with prostate cancer and benign prostatic hyperplasia. Clin Biochem 32: 405-409, 1999.
15. Freeman VL, Meydani M, Hur K and Flanigan RC: Inverse association between prostatic polyunsaturated fatty acid and risk of locally advanced prostate carcinoma. Cancer 101: 2744-2754, 2004.
16. Freeman VL, Flanigan RC and Meydani M: Prostatic fatty acids and cancer recurrence after radical prostatectomy for early-stage prostate cancer. Cancer Causes Control 18: 211-218, 2007. (Pubitemid 46215317)
17. Demark-Wahnefried W, Price DT, Polascik TJ, Robertson CN, Anderson EE, Paulson DF, Walther PJ, Gannon M and Vollmer RT: Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: Exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features. Urology 58: 47-52, 2001.
18. Hamazaki K, Higashihara E, Terachi T, Takada H, Matsuda T, Kawakita M, Fuse H, Hamazaki T, Kameyama S, Masai M, Chiba Y, Tokunaga M, Furuta Y, Okegawa T, Murota T, Kawa G and Itomura M: The effect of eicosapentaenoic acid on prostate-specific antigen. In Vivo 20: 397-402, 2006.
19. Amling CL, Blute ML, Bergstralh EJ, Thomas M, Jeffrey S and Horst Z: Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: Continued risk of biochemical failure after 5 years. J Urol 164: 101-105. 2000.
20. Stephenson AJ, Shariat SF, Zelefsky MJ, Kattan MW, Butler EB, Teh BS, Klein EA, Kupelian PA, Roehrborn CG, Pistenmaa DA, Pacholke HD, Liauw SL, Katz MS, Leibel SA, Scardino PT and Slawin KM: Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA 291: 1325-1332, 2004.
21. Ruiz L, Salomon L, Hoznek A, Vordos D, Yiou R, Taille ADL and Abbou CC: Comparison of early oncologic results of laparoscopic radical prostatectomy by extraperitoneal versus transperitoneal approach. Eur Urol 46: 50-56, 2004.
22. Grønn M, Christensen E, Hagve TA and Christophersen BO: Effects of dietary purified eicosapentaenoic acid (20:5(n-3)) and docosahexaenoic acid (22:6(n-3)) on fatty acid desaturation and oxidation in isolated rat liver cells. Biochim Biophys Acta 1125: 35-43, 1992.
23. Mori TA, Burke V, Puddey IB, Watts GF, O'Neal DN, Best JD and Beilin LJ: Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr 71: 1085-1094, 2000. (Pubitemid 30230554)
24. Christensen JH, Fabrin K, Borup K, Barber Neil and Poulsen J: Prostate tissue and leukocyte levels of n-3 polyunsaturated fatty acids in men with benign prostate hyperplasia or prostate cancer. BJU Int 97: 270-273, 2006.
25. Aronson WJ, Glaspy JA, Reddy ST, Reese D, Heber D and Bagga D: Modulation of omega-3/omega-6 polyunsaturated ratios with dietary fish oils in men with prostate cancer. Urology 58: 283-288, 2001.
26. Mori TA and Woodman RJ: The independent effects of eicospentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans. Curr Opin Clin Nutr Metab Care 9: 95-104, 2006.
27. Harris WS, Mozaffarian D, Lefevre M, Toner CD, Colombo J, Cunnane SC, Holden JM, Klurfeld DM, Morris MC and Whelan J: Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. J Nutr 139: 804S-819S, 2009.